3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
OmniAb reported third-quarter 2026 revenue of $4.0 million, up from $2.2 million a year earlier, and a net loss of $15.7 million, or $0.12 per share, narrowed from $16.5 million, or $0.14 per share. The company raised its full-year 2026 revenue guidance and its year-end cash outlook, which may matter to shareholders because the figures point to higher revenue and a smaller loss than in the prior-year period.
Q3 2026 revenue was $4.0 million versus $2.2 million in Q3 2025; net loss was $15.7 million, or $0.12 per share, versus $16.5 million, or $0.14 per share.
2026 revenue guidance is now $35 million to $39 million, up from $32 million to $36 million previously.
Year-end 2026 cash and cash equivalents outlook is $53 million to $57 million, up from $49 million to $53 million.
In Q3 2026, OmniAb entered a collaboration and license agreement with Eli Lilly and Company eligible for up to $370 million in milestone payments, plus royalties.
Gates Industrial reported third-quarter 2026 net sales of $903.6 million, up 5.6%, with diluted earnings per share of $0.34 versus $0.31 a year earlier and adjusted earnings per share of $0.47 versus $0.39. The company raised its full-year 2026 guidance for adjusted EBITDA and adjusted earnings per share, which benefits shareholders if the outlook is met.
Q3 net sales were $903.6 million, up 5.6%, with core sales up 5.5%.
Diluted EPS was $0.34 versus $0.31; adjusted EPS was $0.47 versus $0.39.
Adjusted EBITDA was $215.4 million, a 23.8% margin versus 22.9% a year earlier.
2026 adjusted EBITDA guidance is $809 million to $823 million (prior $800 million to $830 million); adjusted EPS guidance is $1.66 to $1.72 (prior $1.62 to $1.70).
Kite Realty Group Trust furnished a Q3 2026 investor presentation under Regulation FD. The company reported Q3 NAREIT FFO of $0.53 and Core FFO of $0.52, and its bridge shows the 2026 FFO guidance midpoint moving from $2.09 to $2.10 for both measures, with a range of $2.08 to $2.12. For shareholders, the filing shows a modest guidance increase alongside 3.6% same property NOI growth.
Q3 2026 NAREIT FFO was $0.53 and Core FFO was $0.52
2026 NAREIT and Core FFO guidance range is $2.08 to $2.12, with a midpoint of $2.10, up from a previous midpoint of $2.09
Same property NOI growth was 3.6% in Q3 2026, and the company expects 3.4% to 3.9% for 2026
Net debt to adjusted EBITDA was 5.2x, and Fitch upgraded the company to BBB+ in September 2026
nVent Electric plc announced third-quarter 2026 results featuring record sales of $1.5 billion and raised its full-year guidance for sales and earnings per share. Shareholders benefited from double-digit organic sales growth across all verticals and a regular cash dividend of $0.21 per share.
Reported net sales reached $1.5 billion in Q3 2026, representing a 44 percent increase.
Reported EPS was $1.23, up 68 percent, while adjusted EPS rose to $1.52.
Full-year 2026 reported sales growth guidance was raised to a range of 48 to 49 percent.
Forum Energy Technologies reported third quarter 2026 revenue of $237 million and adjusted EBITDA of $36 million, and raised its full-year 2026 guidance. GAAP diluted EPS was $0.93, down from $1.05 in the prior quarter, while adjusted diluted EPS was $1.51, up from $1.16.
Q3 2026 revenue of $237 million, up 5% sequentially; orders of $244 million and book-to-bill ratio of 103%
Net income of $11 million and diluted EPS of $0.93, versus a net loss of $21 million in Q3 2025; adjusted diluted EPS of $1.51
Full-year 2026 guidance raised to revenue of $900 million to $920 million and adjusted EBITDA of $123 million to $129 million
Q4 2026 guidance: revenue of $230 million to $250 million and adjusted EBITDA of $33 million to $39 million
Civeo reported third quarter 2026 revenue of $193.1 million, up 13% from a year earlier, and net income of $5.2 million, or $0.50 per diluted share, compared with a net loss of $0.5 million in the same quarter of 2025. The company raised its full year 2026 revenue guidance to $710 million to $720 million and its Adjusted EBITDA guidance to $89 million to $92 million, citing higher Canadian oil sands occupancy.
Q3 2026 revenue $193.1 million, up 13% year over year; Canadian revenue up 38%
Q3 2026 net income $5.2 million ($0.50 per diluted share) versus a net loss of $0.5 million a year earlier
Full year 2026 revenue guidance raised to $710 million to $720 million from $675 million to $700 million; Adjusted EBITDA guidance raised to $89 million to $92 million from $85 million to $90 million
Cousins Properties reported third-quarter 2026 results, with FFO of $123.8 million, or $0.75 per share, up from $116.5 million, or $0.69 per share, a year earlier. The company raised its 2026 FFO guidance to $2.95 to $2.99 per share from $2.92 to $2.98, which matters to shareholders because it signals higher expected recurring cash earnings for the year.
Q3 2026 net income available to common stockholders was $17.0 million, or $0.10 per share, versus $8.6 million, or $0.05 per share, in Q3 2025.
2026 FFO per share guidance raised to $2.95 to $2.99 from $2.92 to $2.98; net income guidance raised to $0.14 to $0.18 per share from $0.08 to $0.14.
Nine-month net income available to common stockholders was $18.3 million, or $0.11 per share, down from $44.0 million, primarily due to an impairment charge.
Same property cash-basis NOI rose 7.4% in Q3 2026, and the company sold One Eleven Congress in Austin for a gross sales price of $208.0 million.
World Kinect reported third quarter 2026 results on October 29, 2026, with revenue of $13.27 billion, up 41% from a year earlier, and GAAP diluted EPS of $0.70 versus $0.46. The company raised its full-year 2026 Adjusted EPS guidance to $3.52 to $3.62 per share from $3.20 to $3.40, which signals higher expected per-share earnings for shareholders.
Q3 2026 revenue was $13.27 billion, up 41% year over year, while volume fell 6% to 4.04 million units.
Q3 GAAP net income was $38 million, or $0.70 per diluted share, versus $0.46 a year earlier; Adjusted EPS was $0.99 versus $0.54.
Full-year 2026 Adjusted EPS guidance rose to $3.52 to $3.62 per share, from $3.20 to $3.40.
Q3 free cash flow was $164 million, and operating cash flow was $175 million.
Illumina announced third-quarter 2026 financial results with reported revenue of $1.13 billion, representing a 4.2% increase compared to the prior-year period. Driven by healthy clinical demand and NovaSeq X placements, the company raised its full-year 2026 total revenue guidance to $4.64-$4.66 billion and non-GAAP diluted EPS guidance to $5.40-$5.45.
Reported revenue for Q3 2026 was $1.13 billion, up 4.2% from Q3 2025.
GAAP diluted EPS for Q3 2026 was $1.43, compared to $0.98 in Q3 2025.
Free cash flow for Q3 2026 reached $378 million, compared to $253 million in the prior-year period.
Full-year 2026 revenue guidance was raised to $4.64-$4.66 billion, up from the previous range.
Merit Medical reported third-quarter 2026 revenue of $416.2 million, up 8.4% from a year earlier, and GAAP EPS of $0.70, up 51%. The company raised its full-year 2026 revenue and non-GAAP EPS guidance, and separately disclosed a $45 million cash acquisition of Solo Pace, Inc.
Q3 2026 reported revenue $416.2 million, up 8.4%; organic constant currency revenue up 9%
GAAP gross margin fell to 48.2% from 48.5%; GAAP operating margin rose to 14.1% from 11.1%
Full-year 2026 non-GAAP EPS guidance raised to $4.33-$4.37 from $4.25-$4.35; revenue guidance to $1.635-$1.642 billion from $1.631-$1.643 billion
Solo Pace acquisition completed October 13, 2026 for cash of approximately $45 million
Schneider National reported third-quarter 2026 operating revenues of $1.6 billion, up 9% from $1.5 billion a year earlier, and income from operations of $62.1 million, up 76%. Diluted earnings per share were $0.28 versus $0.11, and the company raised its full-year 2026 adjusted diluted EPS guidance to $1.00 to $1.10. Revenue and profit both improved, which is favorable for shareholders.
Income from operations rose to $62.1 million from $35.3 million; diluted EPS was $0.28 versus $0.11 in Q3 2025.
Full-year 2026 adjusted diluted EPS guidance raised to $1.00 to $1.10; net capital expenditures guidance set at $325 million to $350 million.
Truckload income from operations was $43.7 million, up 121%; Logistics income from operations was zero, down $6.4 million.
Board declared a $0.10 dividend on October 26, 2026, payable January 12, 2027.
Exponent reported third-quarter 2026 total revenues up 18% to $173.7 million and net income of $30.9 million, or $0.64 per diluted share, compared with $0.55 a year earlier. The company raised its full-year 2026 revenue and margin guidance and declared a $0.31 quarterly dividend payable December 18, 2026.
Revenues before reimbursements rose 12% to $153.1 million; EBITDA was $45.0 million, or 29.4% of those revenues.
Full-year 2026 outlook: revenues before reimbursements to grow 10% to 11%, and EBITDA to be 28.0% to 28.3% of revenues before reimbursements.
Fourth-quarter 2026 outlook: revenues before reimbursements to grow 8% to 10%, and EBITDA to be 26.3% to 26.8% of revenues before reimbursements.
Quarterly cash dividend of $0.31 per share, with a record date of December 4, 2026 and payment on December 18, 2026.
Healthcare Realty reported third quarter 2026 results on October 29, 2026, with Normalized FFO of $0.42 per diluted share, up from $0.41 a year earlier, and a GAAP net loss of $(0.05) per share, narrower than the $(0.17) loss in the prior-year quarter. The company raised its full-year 2026 Normalized FFO guidance to $1.65-$1.67 per share from $1.62-$1.66 and raised its Same Store Cash NOI growth guidance to 5.00%-5.25%. Third quarter revenue fell to $286.6 million from $297.8 million a year earlier.
Q3 2026 Normalized FFO of $0.42 per diluted share, versus $0.41 in Q3 2025; NAREIT FFO of $0.38 versus $0.34
Q3 2026 GAAP net loss attributable to common stockholders of $15.8 million, or $(0.05) per share, versus $57.7 million, or $(0.17) per share, a year earlier
Full-year 2026 Normalized FFO guidance raised to $1.65-$1.67 per share from $1.62-$1.66 in July
Quarterly common dividend of $0.24 per share, payable November 20, 2026, to holders of record on November 10, 2026
CareDx reported third-quarter 2026 revenue of $139 million, up 39% from a year earlier, and GAAP net income of $19 million, compared with $2 million in the third quarter of 2025. The company raised its full-year 2026 revenue guidance to $520 million to $530 million and its adjusted EBITDA guidance to $90 million to $100 million, which points to higher expected results for shareholders.
Q3 2026 revenue was $139 million, up 39% year-over-year; Testing Services revenue was $119 million, up 65%.
GAAP diluted net income per share was $0.35, compared with $0.03 in the third quarter of 2025; net income included an $8.6 million income tax benefit.
2026 revenue guidance raised to $520 million to $530 million, from $490 million to $500 million previously.
2026 adjusted EBITDA guidance raised to $90 million to $100 million, from $66 million to $78 million previously.
OSI Systems reported fiscal first-quarter 2027 revenue of $403.5 million, up 5% from a year earlier, and GAAP diluted EPS of $1.51, up 28%. The company raised its fiscal 2027 non-GAAP EPS guidance to $11.28-$11.64 from $11.13-$11.49 and reaffirmed its revenue guidance of $1.875 billion-$1.930 billion, which matters to shareholders because it signals higher expected per-share earnings while the Healthcare division's results were weaker.
Q1 revenue was $403.5 million versus $384.6 million a year earlier; non-GAAP diluted EPS was $1.66 versus $1.42.
Fiscal 2027 non-GAAP EPS guidance raised to $11.28-$11.64; revenue guidance unchanged at $1.875 billion-$1.930 billion.
Healthcare division posted a GAAP operating loss of $2.4 million on revenue of $35.1 million, down from $40.7 million.
Operating cash flow was $37.1 million versus $17.1 million, and backlog reached $2.1 billion as of September 30, 2026.
GATX reported third-quarter 2026 net income attributable to GATX of $105.2 million, or $2.92 per diluted share, up from $82.2 million, or $2.25 per share, a year earlier. The company now expects 2026 full-year earnings to modestly exceed the high end of its previous guidance range of $9.90 to $10.30 per diluted share, which excludes tax adjustments and other items.
Q3 2026 net income attributable to GATX was $105.2 million, or $2.92 per diluted share, versus $82.2 million, or $2.25, in Q3 2025.
Nine-month 2026 net income attributable to GATX was $294.1 million, or $8.11 per diluted share, versus $236.3 million, or $6.46, a year earlier.
Full-year 2026 earnings are now expected to modestly exceed the high end of the prior $9.90 to $10.30 per-share guidance range.
Hershey reported third-quarter 2026 net sales of $3,275.5 million, up 3.0%, and reported net income of $580.8 million, or $2.88 per diluted share, up 111.8%. The company raised its 2026 adjusted EPS growth outlook to 36% to 38.5% from 32.5% to 35%, which includes about $0.22 from tariff refunds received in Q3 2026.
Q3 2026 adjusted EPS was $2.64, up 103.1%, versus reported EPS of $2.88 and $1.36 a year earlier
2026 adjusted EPS growth outlook raised to 36% to 38.5%; reported EPS growth outlook raised to 84% to 90%
2026 net sales growth outlook is about 5%, and organic net sales growth outlook is about 3%
North America Salty Snacks segment income fell 17.9% to $47.4 million in Q3 2026; International segment loss was $30.0 million
Republic Airways reported third-quarter 2026 revenue of $553.5 million, up 34.3% from a year earlier, and net income of $34.6 million, or $0.75 per diluted share, versus $6.7 million, or $0.17, in the prior-year quarter. The company raised its full-year 2026 adjusted EBITDAR guidance to $410 million to $420 million from $395 million to $405 million, and it now expects adjusted diluted EPS above $3.30. Shareholders should note that the results include Mesa, which was merged in on November 25, 2025, so the year-over-year comparison is not like for like.
Q3 2026 revenue was $553.5 million, up $141.5 million, or 34.3%, mainly due to a 26.2% increase in block hour production after the Merger.
Q3 2026 net income was $34.6 million, or $0.75 per diluted share, compared with $6.7 million, or $0.17, in Q3 2025.
Full-year 2026 adjusted EBITDAR guidance was raised to $410 million to $420 million from $395 million to $405 million; revenue guidance of about $2.1 billion was unchanged.
Adjusted diluted EPS guidance of greater than $3.30 was provided, after none had been given on July 30, 2026.
IDACORP reported third quarter 2026 net income attributable to IDACORP of $160.2 million, or $2.73 per diluted share, up from $124.4 million, or $2.26 per diluted share, a year earlier, and raised its full-year 2026 earnings guidance to $6.40 to $6.50 per diluted share from $6.30 to $6.45. The higher guidance and stronger results mainly reflect higher net income at Idaho Power, the company's regulated electric utility, driven by Idaho base rate increases and revenue from large contract customers.
Q3 2026 net income attributable to IDACORP was $160.2 million, or $2.73 per diluted share, versus $124.4 million, or $2.26, in Q3 2025.
Nine-month 2026 net income attributable to IDACORP was $330.8 million, or $5.76 per diluted share, versus $279.9 million, or $5.13, in the same period of 2025.
As of October 29, 2026, 2026 earnings guidance was raised to $6.40 to $6.50 per diluted share from $6.30 to $6.45 as of July 30, 2026.
Idaho Power O&M expense guidance for 2026 was raised to $535 million to $545 million from $525 million to $535 million.
DT Midstream reported third-quarter 2026 net income of $118 million, or $1.16 per diluted share, up from $112 million, or $1.09 per share, in the prior quarter, and raised its 2026 Adjusted EBITDA guidance to $1,185-$1,225 million. The company also declared a quarterly dividend of $0.88 per share, which shareholders of record on December 15, 2026 will receive on January 15, 2027.
Q3 2026 net income of $118 million ($1.16 per diluted share) versus $112 million ($1.09 per share) in Q2 2026; Adjusted EBITDA was $301 million versus $305 million in Q2.
Nine-month 2026 net income was $360 million and Adjusted EBITDA was $914 million, compared with $330 million and $845 million for the same period of 2025.
2026 Adjusted EBITDA guidance raised to $1,185-$1,225 million; the company cited year-to-date results ahead of plan.
Quarterly dividend of $0.88 per share: record date December 15, 2026, payment date January 15, 2027.
WEC Energy Group reported third-quarter net income of $389.3 million, or $1.18 per share, compared to $271.3 million, or 83 cents per share, for the same period last year. Driven by favorable weather and capital investments, the company raised and narrowed its full-year 2026 earnings guidance to a range of $5.60 to $5.64 per share. These results demonstrate solid operational performance that directly benefits shareholders.
Third-quarter net income reached $389.3 million, or $1.18 per share, up from $271.3 million, or 83 cents per share, in the third quarter of 2025.
Full-year 2026 earnings guidance was raised and narrowed to a range of $5.60 to $5.64 per share.
Consolidated revenues for the first nine months of 2026 totaled $7.8 billion, an increase of $523.9 million compared to the same period in 2025.
West Pharmaceutical Services reported third-quarter 2026 net sales of $874.5 million and diluted earnings per share of $3.02, reflecting growth compared to the prior-year period. Driven by strong execution in its Proprietary Products segment, the company raised its full-year net sales and adjusted-diluted EPS guidance ranges.
Q3 2026 net sales reached $874.5 million, up 8.7% year-over-year, with diluted EPS of $3.02.
Full-year 2026 net sales guidance was increased to a range of $3.41 billion to $3.42 billion.
Full-year 2026 adjusted-diluted EPS guidance was raised to a range of $9.38 to $9.48.
The company repurchased $231 million of stock in the third quarter, bringing year-to-date repurchases to $685 million.
Life Time Group Holdings reported third-quarter 2026 revenue of $893.5 million, up 14.2% from a year earlier, with net income of $106.5 million and diluted EPS of $0.46. The company raised its full-year 2026 outlook, including total revenue guidance of $3,380 million to $3,390 million and Adjusted EBITDA guidance of $958 million to $962 million.
Q3 2026 revenue $893.5 million, up 14.2%; net income $106.5 million, up 4.0%; diluted EPS $0.46, up 2.2%
Q3 Adjusted EBITDA $256.3 million, up 16.5%; Adjusted diluted EPS $0.51, up 24.4%
2026 Adjusted EBITDA guidance raised to $958 million to $962 million from $940 million to $955 million
Net debt leverage ratio improved to 1.3 times from 1.6 times a year earlier
Norwegian Cruise Line Holdings reported third quarter 2026 total revenue of $2.9 billion and GAAP net income of $491 million, or $1.07 per share, up from $419 million a year earlier. The company raised its full year 2026 guidance to Adjusted EBITDA of approximately $2.55 billion and Adjusted EPS of approximately $1.70, but Net Yield fell 6.5% in the quarter and Net Leverage ended at 5.5x.
Q3 2026 Adjusted EBITDA was $937 million, above guidance of $874 million; Adjusted EPS was $1.12, above guidance of $0.90
Full year 2026 Adjusted EBITDA guidance is approximately $2.55 billion and Adjusted EPS guidance is approximately $1.70
Q3 2026 Net Yield declined 6.5% on an as reported basis; total debt was $15.1 billion as of September 30, 2026
Issued $950 million of 8.750% senior notes due 2031 on October 15, 2026
Quanta Services reported third-quarter 2026 revenue of $12.01 billion and net income attributable to common stock of $694.9 million, alongside record total backlog of $63.7 billion. Driven by strong performance across its operations, the company significantly increased its full-year 2026 financial expectations across all metrics.
Consolidated revenues for the third quarter of 2026 reached $12.01 billion, up from $7.63 billion in the third quarter of 2025.
Third-quarter 2026 diluted earnings per share was $4.55 on a GAAP basis and $6.06 on an adjusted basis.
Total backlog reached a record $63.7 billion, with remaining performance obligations at $41.8 billion as of September 30, 2026.
For the full year 2026, the company now expects revenues between $41.3 billion and $41.6 billion and adjusted diluted EPS between $17.90 and $18.30.
Trane Technologies reported third-quarter 2026 net revenues of $6.8 billion, representing an 18 percent increase year-over-year, alongside GAAP continuing EPS of $4.79 and adjusted continuing EPS of $4.86. Driven by strong demand and a backlog reaching $12.5 billion, the company raised its full-year 2026 reported revenue growth guidance to approximately 13.5 percent while reaffirming its full-year EPS guidance.
Third-quarter reported revenues reached $6.8 billion, up 18 percent compared with $5.7 billion in the third quarter of 2025.
GAAP continuing EPS was $4.79 and adjusted continuing EPS was $4.86, both increasing 25 percent year-over-year.
Total backlog stood at $12.5 billion as of the end of the third quarter of 2026, up 73 percent.
Full-year 2026 reported revenue growth guidance was raised to approximately 13.5 percent.
Textron reported third-quarter 2026 GAAP EPS of $1.56, up from $1.31, and adjusted EPS of $1.76, up from $1.55, on revenue of $3.8 billion, up 4%. The company raised its full-year 2026 adjusted EPS outlook to $6.55 to $6.65 from $6.40 to $6.60, and its manufacturing cash flow outlook to $800 million to $900 million from $700 million to $800 million, citing U.S. Army approval of funding for the MV-75 Cheyenne program.
Q3 2026 adjusted EPS of $1.76 versus $1.55 a year earlier; GAAP EPS of $1.56 versus $1.31
Full-year 2026 GAAP EPS outlook raised to $5.64 to $5.74 from $5.39 to $5.59
Bell revenues fell 9% to $933 million, largely on lower MV-75 volume, while Textron Aviation revenues rose 14% to $1.7 billion
Textron returned $239 million to shareholders through share repurchases in the quarter
Protolabs reported record third-quarter 2026 revenue of $154.3 million, up 14.0% year over year, and GAAP diluted earnings per share of $0.48, up from $0.30. The company raised its full-year 2026 revenue growth guidance to 10% to 11% and expects fourth-quarter revenue of $143.0 million to $151.0 million, which gives shareholders a higher outlook alongside higher quarterly profit.
Q3 2026 revenue was a record $154.3 million, up 14.0% from the third quarter of 2025.
GAAP diluted EPS was $0.48 versus $0.30; non-GAAP diluted EPS was $0.63 versus $0.47.
Full-year 2026 revenue growth guidance raised to 10% to 11% from 8% to 10%.
Q4 2026 guidance: revenue of $143.0 million to $151.0 million; GAAP diluted EPS of $0.28 to $0.36.
WESCO International reported record third quarter 2026 net sales of $7.2 billion, up 17% year over year, and diluted EPS of $5.43 versus $3.79 a year earlier. The company also said it is raising its full-year 2026 outlook and that backlog rose about 80% year over year to a record.
Q3 2026 net sales $7,226.4 million, up 16.6% from $6,199.1 million; data center sales of $1.8 billion, up about 55%
Q3 diluted EPS $5.43 vs $3.79; adjusted diluted EPS $5.77, up 47.2%
Q3 operating cash flow $193.9 million vs negative $82.7 million a year earlier; financial leverage 2.8x vs 3.4x at 2025 year-end
Full-year 2026 outlook raised; webcast scheduled for October 29, 2026 at 10:00 a.m. E.T.
Hippo reported third-quarter 2026 revenue of $156 million, up 29% from a year earlier, and adjusted net income of $20 million, or $0.74 per diluted share. GAAP net income fell to $9 million from $98 million, which included a $95 million gain on a business sale in the prior-year quarter. The company raised its full-year 2026 adjusted net income guidance to $77 million to $80 million from $62 million to $70 million.
Q3 2026 revenue was $156 million, up from $120.6 million in Q3 2025; gross written premium rose 60.1% to $498 million.
GAAP net income was $9 million, or $0.33 per diluted share, versus $98 million in Q3 2025, which included a $95 million gain on sale of a business.
Adjusted net income was $20 million, or $0.74 per diluted share, compared with $18.3 million, or $0.70, a year earlier.
Full-year 2026 guidance: adjusted net income raised to $77 million to $80 million from $62 million to $70 million; combined ratio improved to 97% to 98% from 99% to 101%.
Xcel Energy reported third-quarter 2026 GAAP earnings of $960 million, or $1.52 per share, up from $524 million, or $0.88 per share, in the third quarter of 2025. The company narrowed its full-year 2026 ongoing earnings per share guidance to a range of $4.10 to $4.16 and initiated 2027 ongoing EPS guidance at $4.48 to $4.62.
Third-quarter 2026 diluted GAAP and ongoing earnings per share were $1.52, compared with GAAP earnings of $0.88 and ongoing earnings of $1.24 in Q3 2025.
Xcel Energy narrowed its 2026 ongoing earnings per share guidance to $4.10 to $4.16.
The company initiated its 2027 ongoing earnings per share guidance of $4.48 to $4.62.
Base capital expenditures for 2027 through 2031 are projected to total $70,000 million.
WEX reported third-quarter 2026 results on October 28, 2026, with revenue of $780.1 million, up 12.8%, and both GAAP and adjusted diluted earnings per share higher than a year earlier. The company raised its full-year 2026 revenue and adjusted earnings per share guidance and repurchased about $200 million of shares in the quarter. Operating cash flow was negative $11.2 million in the quarter, compared with $376.6 million provided a year earlier, which shareholders may weigh against the higher earnings.
Q3 2026 revenue of $780.1 million rose 12.8%; GAAP diluted EPS of $3.88 rose 68.7% and adjusted diluted EPS of $6.13 rose 33.6%.
Full-year 2026 adjusted EPS guidance was raised to $21.28 to $21.48 from $19.68 to $20.08; revenue guidance was raised to $2.97 billion to $2.99 billion from $2.86 billion to $2.90 billion.
Net cash used for operating activities was $11.2 million in Q3 2026, compared with $376.6 million provided in Q3 2025.
Share repurchases were about $200 million in Q3 2026, with an additional $75 million through October 26.
Encompass Health reported third-quarter 2026 net operating revenue of $1.6 billion, up 8.9% from a year earlier, and diluted earnings per share from continuing operations of $1.51, up from $1.24. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA and adjusted earnings per share, which gives shareholders a higher expected range for the year.
Q3 2026 net operating revenue was $1,609.5 million, up 8.9% from $1,477.5 million; Adjusted EBITDA was $346.6 million, up 15.5%.
Diluted EPS from continuing operations was $1.51 versus $1.24; adjusted EPS was $1.52 versus $1.23.
2026 adjusted EPS guidance rose to $6.23 to $6.37 from $6.02 to $6.25; Adjusted EBITDA guidance rose to $1,395 million to $1,415 million from $1,365 million to $1,395 million.
Management will discuss the results on an earnings call at 10:00 a.m. Eastern Time on Thursday, October 29, 2026.
EPR Properties reported third-quarter 2026 total revenue of $204.1 million, up 12.0% from a year earlier, and net income available to common shareholders of $94.1 million, up 55.5%. The company raised its 2026 FFOAA per diluted share guidance to $5.49 to $5.57 from $5.41 to $5.57, and raised its investment spending guidance to $675.0 million to $725.0 million from $600.0 million to $700.0 million.
Q3 2026 diluted net income per share was $1.22, versus $0.79 in Q3 2025; FFOAA per diluted share was $1.49, up 8.8%.
Nine-month 2026 total revenue was $581.4 million, up 8.6%, and nine-month net income available to common shareholders was $211.8 million, up 11.5%.
Q3 2026 investment spending was $172.4 million, bringing nine-month spending to $664.5 million.
A new $1.6 billion credit agreement took effect on July 17, 2026, and a $600.0 million term loan was fully drawn as of September 30, 2026.
Equinix reported third-quarter 2026 revenues of $2.571 billion and net income of $489 million, alongside record annualized gross bookings of $533 million. Driven by robust demand for traditional and AI workloads, the company raised its full-year 2026 guidance for the third consecutive quarter, signaling continued momentum for shareholders.
Q3 2026 revenues reached $2.571 billion, representing an 11% increase year over year.
Delivered record annualized gross bookings of $533 million, up 35% year over year.
Raised full-year 2026 revenue guidance to between $10.325 and $10.365 billion.
Reported Q3 net income attributable to common stockholders of $489 million, or $4.93 per diluted share.
Glaukos reported third-quarter 2026 net sales of $211.0 million, up 58% from $133.5 million a year earlier, and GAAP net income of $2.0 million, or $0.03 per diluted share, compared with a net loss of $16.2 million in the prior-year quarter. The company raised its 2026 net sales guidance to $775 million to $785 million from $680 million to $700 million and gave preliminary 2027 net sales guidance of $1 billion.
Q3 2026 net sales were $211.0 million, up 58% year over year; U.S. Glaucoma sales were $118.6 million and Corneal Health sales were $59.0 million.
GAAP net income was $2.0 million, or $0.03 per diluted share; non-GAAP net income was $28.5 million, or $0.47 per diluted share.
2026 net sales guidance was raised to $775 million to $785 million from $680 million to $700 million.
Cash, short-term investments and restricted cash were $339.8 million at September 30, 2026, up $50.5 million from June 30, 2026, with no debt.
Fortinet reported third-quarter 2026 revenue of $2.08 billion and GAAP earnings per share of $0.86, driven by 20% year-over-year revenue growth. The company raised its full-year 2026 revenue guidance and increased its share repurchase authorization by $1.2 billion.
Revenue grew 20% year-over-year to $2.08 billion for the third quarter ended September 30, 2026.
GAAP earnings per share were $0.86, with non-GAAP earnings per share at $0.91.
Share repurchase authorization was increased by $1.2 billion, leaving a remaining authorization of $2 billion.
Full-year 2026 revenue guidance was updated to a range of $8.125 billion to $8.215 billion.
T-Mobile US reported its third-quarter 2026 financial results, highlighting year-over-year increases in service revenues, net income, and diluted earnings per share alongside growth in postpaid accounts. The company also raised the midpoint of several full-year 2026 financial guidance metrics, including Core Adjusted EBITDA and Adjusted Free Cash Flow. For shareholders, these results reflect continued operational momentum and stronger cash flow generation expectations.
Diluted earnings per share grew 34% year-over-year to $3.22 for the third quarter of 2026.
Total service revenues increased 6% year-over-year to $19.4 billion in Q3 2026.
Full-year 2026 Core Adjusted EBITDA guidance was raised to between $37.35 billion and $37.45 billion at the midpoint.
Stockholder returns reached $3.5 billion in Q3 2026 through $2.4 billion in share repurchases and $1.1 billion in cash dividends.
The E.W. Scripps Company raised its full-year 2026 midterm Local Media political advertising revenue expectation to about $275 million, up from the $225-$250 million range it gave in August. It also completed 431 workforce reductions, bringing its 2026 total to about 850 employees, nearly 20% of its headcount at the start of the year. The filing gives no full third-quarter earnings; those are due after the market closes on Nov. 5.
Full-year 2026 political revenue expectation raised to about $275 million, versus the August guidance of $225-$250 million.
Third-quarter Local Media political revenue was nearly $81 million; the company had $83 million in cash at quarter end.
431 workforce reductions completed on Tuesday, bringing 2026 total to about 850 employees, nearly 20% of the start-of-year count.
Company plans to pay down at least $150 million of debt in the fourth quarter; full Q3 results due Thursday, Nov. 5.
Hayward Holdings reported third-quarter fiscal 2026 results for the period ended September 26, 2026, with net sales up 6% to $260.1 million and net income up 35% to $32.4 million. The company raised its full-year 2026 guidance, now expecting adjusted diluted EPS of $0.86 to $0.88, up from $0.84 to $0.87 previously.
Net sales rose 6% to $260.1 million; North America sales rose 9% to $226.4 million while Europe & Rest of World fell 6% to $33.8 million
Net income rose 35% to $32.4 million; diluted EPS rose 36% to $0.15, and adjusted diluted EPS rose 29% to $0.18
Full-year 2026 guidance raised: net sales now expected to grow about 5% to 6% (prior: about 5%); adjusted diluted EPS now $0.86 to $0.88 (prior: $0.84 to $0.87)
Operating cash flow for the nine months fell $57.5 million year over year, mainly due to timing of collections and inventory purchases
Bausch + Lomb reported third-quarter 2026 revenue of $1.375 billion, up 7% from $1.281 billion a year earlier, and GAAP net income attributable to the company of $32 million, compared with a $28 million loss in the third quarter of 2025. The company raised its full-year 2026 revenue guidance and its adjusted EBITDA excluding acquired IPR&D guidance, which signals higher expected full-year results for shareholders.
Q3 2026 revenue was $1.375 billion, up $94 million or 7% from Q3 2025 (8% on a constant currency basis)
GAAP net income was $32 million, or $0.09 per share, versus a $28 million loss in Q3 2025
Full-year 2026 revenue guidance raised to $5.450 billion-$5.550 billion from $5.440 billion-$5.540 billion as of July 29, 2026
Full-year 2026 adjusted EBITDA excluding acquired IPR&D guidance raised to $1.090 billion-$1.140 billion from $1.025 billion-$1.075 billion
Masco reported third quarter 2026 net sales of $1,966 million, up 3 percent from a year earlier, and adjusted earnings per share of $1.19, up 23 percent. The company raised its 2026 adjusted earnings per share guidance to $4.65 to $4.75 from $4.40 to $4.60, which is favorable for shareholders, though management said it expects the demand environment to remain challenged in the near term.
Net sales rose 3 percent to $1,966 million; excluding the Bristan divestiture and currency, sales rose 4 percent
Reported earnings per share were $1.17, up 30 percent from $0.90; adjusted earnings per share were $1.19, up 23 percent from $0.97
2026 adjusted earnings per share guidance raised to $4.65 to $4.75 from $4.40 to $4.60
Returned $322 million to shareholders through dividends and buybacks; declared a $0.32 per share quarterly dividend payable November 23, 2026
IDEX reported record third-quarter 2026 net sales of $952 million, up 8% from a year earlier, and diluted EPS of $1.95, up 15%. The company raised its full-year 2026 guidance for organic sales growth and adjusted diluted EPS, which gives shareholders a higher outlook for the year.
Q3 net sales of $951.7 million rose 8%; organic sales also rose 8%, with orders up 13% to $991.2 million
Diluted EPS attributable to IDEX was $1.95 versus $1.70; adjusted diluted EPS was $2.33 versus $2.03, up 15%
Full-year adjusted diluted EPS guidance raised to $8.91 to $8.96 from $8.70 to $8.85
Full-year organic sales growth guidance raised to 6.5% to 6.8% from 5% to 6%
GE Vernova Inc. reported third-quarter 2026 revenue of $12.6 billion and net income of $1.3 billion, driven by strength in its Power and Electrification segments. Based on strong performance and growing infrastructure demand, the company raised its full-year 2026 financial guidance and increased its share repurchase authorization to $20 billion.
Constellium reported third quarter 2026 revenue of $2.6 billion, up 22% from a year earlier, and net income of $119 million, compared with $88 million in Q3 2025. The company raised its 2026 Adjusted EBITDA guidance to $1.03 billion to $1.06 billion, excluding the non-cash metal price lag, and now expects Free Cash Flow above $300 million, which is a positive signal for shareholders.
Q3 2026 revenue of $2.6 billion, up 22%; shipments of 368 thousand metric tons, down 1%
Q3 2026 net income of $119 million vs. $88 million; Adjusted EBITDA of $276 million vs. $235 million
2026 Adjusted EBITDA guidance raised to $1.03 billion to $1.06 billion, excluding metal price lag; Free Cash Flow expected above $300 million
Leverage of 1.6x at September 30, 2026; on October 22, 2026 the Pan-U.S. ABL commitments rose from $550 million to $700 million
OGE Energy reported third quarter 2026 diluted earnings of $1.52 per share, up from $1.14 a year earlier, on net income of $316.2 million versus $231.3 million. The company now expects 2026 consolidated earnings of $2.62 to $2.68 per diluted share, above its original guidance range, citing warmer than normal weather.
Q3 2026 diluted EPS was $1.52 versus $1.14 in Q3 2025; net income was $316.2 million versus $231.3 million.
Operating revenues rose to $1,182.8 million from $1,045.0 million, with OG&E's results driven by significantly warmer weather.
2026 guidance now calls for consolidated earnings of $2.62 to $2.68 per diluted share, assuming normal weather for the rest of the year.
Slide reported third-quarter 2026 net income of $138.2 million, up 24.5% from a year earlier, and raised its full-year 2026 net income outlook to $500 million to $520 million. The combined ratio rose to 59.3% from 48.5% on higher catastrophe losses, a headwind for underwriting profitability. The company also entered a $1.072 billion secured credit agreement with Huntington National Bank and declared a $1.50 per share special dividend, payable November 30, 2026.
Q3 2026 net income $138.2 million, up 24.5%; diluted EPS $1.09, up 37.3% from $0.79
Full-year 2026 net income outlook raised to $500 million-$520 million from $455 million-$470 million
New credit agreement with Huntington National Bank totals $1.072 billion, maturing October 26, 2031, replacing the $530.4 million existing facility
One-time special dividend of $1.50 per share plus $0.07 quarterly dividend, payable November 30, 2026 to holders of record November 23, 2026
Nabors reported third quarter 2026 operating revenues of $872 million, up 7% from the second quarter, and adjusted EBITDA of $246 million, up nearly 11% sequentially. The company still posted a net loss attributable to shareholders of $11 million, or $1.24 per share, and raised its full-year adjusted free cash flow outlook to $100 million to $110 million, which it called materially higher than prior guidance.
Q3 2026 operating revenues $872 million, up from $814.8 million in Q2 2026 and $818.2 million in Q3 2025
Net loss attributable to Nabors shareholders $11 million ($1.24 per diluted share), versus net income of $274.2 million in Q3 2025, which included a Quail Tools gain
Adjusted free cash flow $75 million in Q3 2026; full-year 2026 outlook raised to $100 million to $110 million
Full-year 2026 adjusted EBITDA expected at about $930 million, the upper end of prior guidance; Q4 2026 adjusted free cash flow expected at $60 million to $70 million
American Assets Trust reported third-quarter 2026 results on October 27, 2026, with FFO of $0.56 per diluted share, up from $0.49 a year earlier, and net income to common stockholders of $0.13 per share, up from $0.07. The company raised its 2026 FFO per diluted share guidance to a range of $2.04 to $2.10, a $0.04 increase at the midpoint. Nine-month net income fell to $18.0 million from $52.5 million, mainly because of a 2025 gain on a property sale.
Q3 2026 FFO was $0.56 per diluted share, compared with $0.49 in Q3 2025.
Q3 2026 total revenue was $114.3 million, compared with $109.6 million in Q3 2025.
2026 FFO per diluted share guidance rose to $2.04 to $2.10 from $1.96 to $2.10, with a midpoint of $2.07.
Nine-month net income attributable to common stockholders was $18.0 million, compared with $52.5 million, mainly due to the 2025 gain on the Del Monte Center sale.
W. P. Carey reported third-quarter 2026 results on October 27, 2026, with revenues up 8.6% to $468.3 million and AFFO per diluted share up 6.4% to $1.33. The company raised and narrowed its full-year 2026 AFFO per diluted share guidance to $5.23-$5.29 from $5.19-$5.27, which points to higher cash earnings per share for shareholders. GAAP diluted earnings per share fell to $0.61 from $0.64, partly reflecting a $35.8 million unrealized loss on the company's Lineage shares.
Revenues including reimbursable costs were $468.3 million, up 8.6% from $431.3 million in the third quarter of 2025.
AFFO per diluted share was $1.33, up 6.4% from $1.25; GAAP diluted EPS was $0.61 versus $0.64, and net income attributable to W. P. Carey was $141.0 million, unchanged year over year.
2026 AFFO per diluted share guidance was raised to $5.23-$5.29 from $5.19-$5.27, and investment volume guidance was narrowed to $1.8-$2.1 billion.
The quarterly cash dividend was increased to $0.950 per share, an annualized $3.80, up 4.4% from the third quarter of 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.